BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
The Food and Drug Administration (FDA) has an approach for the expanded use of Omalizumab (Xolair), to address allergic reactions, including anaphylaxis, stemming from accidental exposure to various foods.
Researchers from Amsterdam UNC and Radboundumc have revealed a method to predict the effectiveness of antidepressants within a week of treatment
This advancement powered by...
Biologic therapies can effectively control severe asthma without the need for regular high-dose inhaled steroids, a significant revelation that could transform the lives of millions grappling with the condition.
A new Artificial intelligence (AI) system has been designed to examine specialised brain MRIs and proved accurate in diagnosing autism in children aged 24 to 48 months.
Researchers at Washington State University have created a groundbreaking surgical implant that demonstrated 87% effectiveness in destroying the bacteria responsible for staph infections in laboratory trials.
A new policy brief from the European Observatory created with and for the Swedish Presidency of the Council of the EU details concrete steps for urgent action on AMR.
Research conducted by the University of Surrey suggests that insulin icodec, a weekly basal injection, may be just as effective when treating type 1 diabetes compared to daily basal insulin treatments.
